Skip to main content
Fig. 6 | Clinical Epigenetics

Fig. 6

From: Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival

Fig. 6

Distribution of hyper- and hypomethylated CpGs correlated with melanoma patients’ outcomes according to their genome location and number of associated genes. A The number of hyper- and hypomethylated CpGs correlated with overall survival is shown according to their location in islands, shores, shelves and open sea regions, for malignancy and metastasis signatures. B The distribution of hyper- and hypomethylated CpGs along genomic regions is shown according to their correlation with a good or poor prognosis for malignancy and metastasis signatures. C. The number of genes from both signatures containing at least two CpGs correlating with melanoma patient outcome is shown

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us